Smith & Nephew SNATS, Inc.

SNN Healthcare Medical Devices

Smith & Nephew SNATS, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $6.2 billion, up 6.09% from fiscal 2024.

31.12 0.89 −2.78%
Market cap
$13.4B
P/E
38.9×
Fwd P/E
18.9×
Dividend yield
2.49%
F-score
7/9
Altman Z
3.49
Beneish M
−2.70
Dividend safety
61/100

Smith & Nephew SNATS, Inc. (SNN) Book value per share

Alert me on Book value per share

Smith & Nephew SNATS, Inc.'s book value per share at the end of fiscal 2025 was 12.2×, unchanged from fiscal 2024. At the end of the quarter to 30 June 2026 it was 0.0×. Over the past ten years it has ranged from 8.9× (fiscal 2015) to 12.7× (fiscal 2021); the current reading is higher than 91% of that period. Smith & Nephew SNATS, Inc. ranks 122nd of 149 Medical Devices companies by book value per share.

Book value per share, annual

Embed this chart

Annual newest first

Period Book value per share Change
FY2025 12.2× 1.15%
FY2024 12.1× 0.69%
FY2023 12.0× (0.68%)
FY2022 12.1× (5.01%)
FY2021 12.7× 5.23%
FY2020 12.1× 2.57%
FY2019 11.8× 5.36%
FY2018 11.2× 5.07%
FY2017 10.6× 19.48%
FY2016 8.9× 0.25%

Quarterly newest first

Period Book value per share Change
Jun 2026 0.0× —
Dec 2025 0.0× —
Jun 2025 0.0× —
Dec 2024 0.0× —
18 more quarters

Against its own ten years

Low 8.9× High 12.7×
Ten-year median 12.0×
Current reading's percentile 91

Book value per share against peers

What Book value per share is

BV per Share tells an investor how much of a company’s accounting net worth stands behind each share.

(Shareholders Equity (Total) ÷ Shares (Basic, Weighted))

The full definition of Book value per share →

More on SNN